ArticleParasites & vectors2024

Artemisinin-naphthoquine plus lower-dose primaquine to treat and prevent recurrence of Plasmodium vivax malaria: an open-label randomized and non-inferiority trial.

Hui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.